SomaLogic announces FDA collaboration to advance biosimilar development

SomaLogic announces FDA collaboration to advance biosimilar development

BOULDER -- SomaLogic, Inc . announced an agreement with the U.S. Food and Drug Administration’s Division of Applied Regulatory Science to evaluate the utility of large-scale analysis of proteins... Read More

Monday November 2, 2020 0 comments Tags: Boulder, SomaLogic, FDA, Stephen Williams, SomaScan Platform